See this page online at: http://www.biotechfocus.com/2006Issue9


  • Make this your homepage
  • Print this Page


Magazine

Sign up for your free subscription and keep up-to-date.


Upcoming Events


Newsletters

Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.


Email Address

BIOTECHNOLOGY FOCUS

SEPTEMBER 2006 ~ ISSUE 9, VOLUME 9


You Can't Win Them All By Amber Lepage-Monette

Bill 102 comes close to satisfying stakeholders

Making everyone happy with Bill 102 is proving tricky for the Ontario government, despite the widespread feeling that something needs to be done to fix the current system.


The Transition Year By Amber Lepage-Monette

Picking the lead candidates for Transition Therapeutics will be a decisive move for Tony Cruz, PhD.

Transition Therapeutics Inc. isn't a company that sits back and lets things happen. This Toronto-based biopharmaceutical firm is all about action.


Pharmacogenomics and Information-based Medicine By Michael Hehenberger, PhD and Guido Roumans

The discipline of pharmacogenomics is aimed at discovering patterns in DNA, RNA, protein expression and biomarker data that correlate with disease risk, disease progression and drug response (clinical outcome)in an individual or a group of patients.